Tagged with IT

pharma   Mitel Distributing Corp is one of Puerto Rico’s leading distributors for weights and scales in the life science industry. The executive team speaks about the challenges of Puerto Rico’s recession and ways that the company has adapted as a result. What have been the biggest opportunities and challenges over…

pharma The country manager of Roche Diagnostics SA, Rajen Bhimaraj highlights the current gaps in the country’s healthcare system and elaborates on how the company’s various community initiatives, such as AmpliCare and the Roche Scientific Campus, are helping to address those gaps. He also evaluates the role of diagnostics in tackling…

pharma Leonardo Vingiani, Director of Assobiotec, discusses how the country’s biotech industry has evolved since 2009, what areas still need improving and the enormous progress which has been made in unlocking the sector’s potential in Italy. Leonardo, to start off, what are some of the major milestones which the industry, and…

pharma The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why South Africa acts as a springboard for many companies looking to develop their footprint in the region, making it the…

pharma Thomas Würdinger, winner of the 2014 Galenus prize, discusses his research team’s efforts to developing new treatment options and protocols for brain cancers, and the need for greater attention and investment in brain cancer treatment development, an area he identifies as the greatest unmet medical need in the field of…

pharma  David Lenihan, CEO of Ponce Health Sciences University (PHSU), and Kenira Thompson, president of the Ponce Research Institute, highlight the institution’s pioneering efforts in creating cultural competency for medical graduates and increasing investments in clinical research from the US for large-scale trials. What are your perceptions of Puerto Rico’s research…

QuantiLAB After recently signing a service level agreement with Mérieux NutriSciences in May 2015, Bertrand Baudot, Managing Director of QuantiLAB explains the company’s plans for the future. He also discusses the challenges and, more importantly, highlights the various opportunities in the Healthcare and Life Sciences sector on Mauritius. In its first…

pharma ”The Mon Trésor Smart City will cater to the business needs of the global healthcare and life sciences sector as no other smart city can.” The Head of Property Development of Omnicane Mauritius explains why while explaining the significance of the project for the sustainable development of the Mauritian economy. There…

pharma Jörg Buck, the Executive Director of the Italian-German Chamber of Commerce discusses the close trade relationship which ties the two countries together, how the business environment in Italy is evolving today and the need to keep the momentum in the economic recovery. To start off, having joined the chamber recently,…

Pharma Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can you please give an overview of Medreich’s activites in South Africa, and how the Meiji acquisition has affected the company’s strategic outlook? The…

Pharma The managing director of Trinity Pharma, Gaby Simaan (Jnr) depicts Trinity’s evolution from a regulatory consultancy into a fully commercialized pharmaceutical company, and how their unique position in the private label space has allowed the company to significantly expand its pipeline of products and presence in the market. To begin,…

Pharma The CEO of Diaxonhit Group, a fully integrated French leader in in vitro diagnostics, discusses the company’s strategic focus on specialty vitro diagnostics, his perspective on the challenge of consolidation that the diagnostics industry faces, as well as his cautiously optimistic assessment of  French competitiveness in the pharmaceutical and life…